EX-5.1 3 ex5-1.htm EXHIBIT 5.1 - OPINION

Exhibit 5.1



MorphoSys AG Postfach 16 58 82145 Planegg
MorphoSys AG
Semmelweisstrasse 7
82152 Planegg
Germany
United States Securities and Exchange Commission
450 Fifth Street N.W.
Washington, DC 20549
United States of America
 
Telefon:
Fax:
Email:
Internet:    
 
+49 (0)89 899 27-0
+49 (0)89 899 27-222
info@morphosys.com
www.morphosys.com
 









November 5, 2019
Contact:
Klaus de Wall
Phone:
+49 89 89927 331


Form S-8

Ladies and Gentlemen,
I refer to the Registration Statement on Form S-8 (the “Registration Statement”) of MorphoSys AG, a German stock corporation (the “Company”), under the Securities Act of 1933 (the “Securities Act”). The Registration Statement relates to up to 127,357 ordinary shares, no par value, of the Company (the “Securities”), issued under the Restricted Stock Unit Program 2019 (US Inc.), offered to certain employees of MorphoSys US Inc.
I have examined and am familiar with (i) the Company’s Articles of Association and (ii) the corporate procedures relating to the issuance of the Securities. Upon the basis of the foregoing, and having satisfied myself as to such other matters of law and fact as I consider relevant for the purposes of this opinion, I advise you that, in my opinion, upon issuance, the Securities will have been legally issued, fully paid and non-assessable.
I express no opinion herein, on or with respect to, any law other than the laws of Germany, and I express no opinion on, or with respect to, the laws of the United States, any state thereof or any other laws, statutes, regulations or ordinances.
I hereby consent to the filing of this opinion as an exhibit to the Registration Statement and any reference to me therein. In giving such consent, I do not hereby admit that I am in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.


Management Board
Dr. Jean-Paul Kress (Vorsitzender),
Dr. Markus Enzelberger,
Jens Holstein, Dr. Malte Peters
Chairman of the Supervisory Board
Dr. Marc Cluzel
 
Bank details
Commerzbank
Sort code: 700 800 00
Account No.: 0349775600
IBAN: DE73 7008 0000 0349 7756 00
SWIFT (BIC): DRESDEFF700
 
Tax No.
9143/101/21259
VAT-ID. No.
DE 15506 9821
 
Registered Office
Planegg, Landkreis München
Commercial register
AG München HRB 121023






Very truly yours,



/s/ Charlotte Lohmann               

Charlotte Lohmann
General Counsel
MorphoSys AG



/s/ Klaus de Wall                       

Klaus de Wall
Head of Accounting & Tax
MorphoSys AG

- 2 -